| First Author | Takemura T | Year | 2013 |
| Journal | Biochem Biophys Res Commun | Volume | 437 |
| Issue | 2 | Pages | 185-91 |
| PubMed ID | 23743191 | Mgi Jnum | J:204425 |
| Mgi Id | MGI:5532476 | Doi | 10.1016/j.bbrc.2013.05.097 |
| Citation | Takemura T, et al. (2013) Conditional loss of heparin-binding EGF-like growth factor results in enhanced liver fibrosis after bile duct ligation in mice. Biochem Biophys Res Commun 437(2):185-91 |
| abstractText | Our aims were to evaluate the involvement of heparin-binding EGF-like growth factor (HB-EGF) in liver fibrogenesis of humans and mice and to elucidate the effect of HB-EGF deficiency on cholestatic liver fibrosis using conditional HB-EGF knockout (KO) mice. We first demonstrated that gene expression of HB-EGF had a positive significant correlation with that of collagen in human fibrotic livers, and was increased in bile duct ligation (BDL)-induced fibrotic livers in mouse. We then generated conditional HB-EGF knockout (KO) mice using the interferon inducible Mx-1 promoter driven Cre recombinase transgene and wild type (WT) and KO mice were subjected to BDL. After BDL, KO mice exhibited enhanced liver fibrosis with increased expression of collagen, compared with WT mice. Finally, we used mouse hepatic stellate cells (HSCs) to examine the role of HB-EGF in the activation of these cells and showed that HB-EGF antagonized TGF-beta-induced gene expression of collagen in mouse primary HSCs. Interestingly, HB-EGF did not prevent the TGF-beta-induced nuclear accumulation of Smad3, but did lead to stabilization of the Smad transcriptional co-repressor TG-interacting factor. In conclusion, our data suggest a possible protective role of HB-EGF in cholestatic liver fibrosis. |
